{"id":326,"date":"2015-06-03T10:02:59","date_gmt":"2015-06-03T09:02:59","guid":{"rendered":"http:\/\/www.madrimasd.org\/blogs\/msca\/?p=326"},"modified":"2015-06-03T10:11:45","modified_gmt":"2015-06-03T09:11:45","slug":"the-ramon-y-cajal-health-research-institute-irycis-is-seeking-to-develop-collaborative-proposals-if-msca-2015","status":"publish","type":"post","link":"https:\/\/www.madrimasd.org\/blogs\/msca\/2015\/06\/03\/326\/","title":{"rendered":"The Ram\u00f3n y Cajal Health Research Institute (IRYCIS), is seeking to develop collaborative proposals IF-MSCA-2015"},"content":{"rendered":"

Brief Description of the Institution<\/strong><\/p>\n

\"\"<\/a>The Ram\u00f3n y Cajal Health Research Institute (IRYCIS), Madrid, Spain, is seeking to develop collaborative funding proposals with experienced postdoctoral researchers for submission under European funding programmes in the area of health research<\/em>. The IRYCIS is a health research institute cantered by a university hospital (Hospital Universitario Ram\u00f3n y Cajal<\/strong>) which includes research groups from three Spanish universities.<\/p>\n

In 2014 IRYCIS had a portfolio of 109 public research projects, 669 clinical trials, more than 60 innovation projects, more than 30 patent applications and a total of 596 publications with an accumulated impact factor of 2,664.546. We have 16 facilities in our premises, aimed to support research (genomics, proteomics, biobank, biostatistics, microarrays, histology, clinical trials unit, confocal microscopy, etc.)<\/p>\n

There are 24 established research groups within IRYCIS organized in five research priority areas:<\/p>\n

    \n
  1. \u00a0 Neurosciences and Sensory Organs;<\/li>\n
  2. \u00a0 Microbiology, Immunology and Infection;<\/li>\n
  3. \u00a0 Cancer and Chronic Diseases;<\/li>\n
  4. \u00a0 Epidemiology and Health Technology;<\/li>\n
  5. \u00a0 Cardiometabology and Systems Pathology.<\/li>\n<\/ol>\n

    \"\"<\/a>Brief Description of the hosting group<\/strong><\/p>\n

    The Diabetes, Obesity and Human Reproduction Research Group (DORH)<\/strong> has a leading international role in the study of androgen excess and chronic metabolic disorders. The DORH group conducts a broad range of clinical studies covering from epidemiology to diagnosis and non-commercial and commercial clinical trials. It also excels in the translation of the results of non-targeted -omic techniques to health problems of clinical relevance. DORH is a small and interdisciplinary research group, including clinical and basic researches that belong to the Ram\u00f3n y Cajal Health Research Institute (IRYCIS) and to the Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM).<\/p>\n

    Our current research is now focusing on the effects of sex hormones and its imbalance on the metabolic and inflammatory effects of the different macronutrients. Furthermore we aim to identify of pathogenic markers of diabetes in severe obesity and predictors of its remission after bariatric surgery.<\/p>\n

    We offer the possibility to work in a highly stimulating clinical environment with a collaborative work atmosphere.<\/p>\n

    For more information about our group, please, visit the following link<\/a><\/p>\n

    Research Project Description<\/strong><\/p>\n

    The DORH group is currently interested in exploring the influence of sex and sex hormones on human chronic disorders of complex etiology. We hypothesize that sex and sex hormones influence, in adults up to the reproductive age, the development and possibly the clinical presentation of many chronic disorders of complex etiology.<\/p>\n

    The project will involve the study of sex and sex hormones roles in the development of cardiometabolic dysfunction associated with severe obesity in humans, and the identification of biomarkers associated with its improvement after metabolic surgery. Specifically, the candidate will carry out non-targeted -omic approaches followed by classic targeted techniques to identify molecules involved in the development of the disorders under study. These molecules could potentially serve as novel and useful diagnostic biomarkers, prognostic factors and therapeutic targets.<\/p>\n

    Applying candidates should have a Master Degree in sciences, biology or similar. As the project involves some non-targeted -omics techniques, candidates with a background in these techniques (trancriptomics, proteomics and metabolomics) are especially encouraged to apply. Background in biostatistics and data analysis will be positively evaluated as well as flexibility at work, self-motivation, and a positive attitude.<\/p>\n

    The candidate cannot have been working or staying in Spain for more than 12 months over the 3 years prior to the to the reference recruitment date.<\/p>\n

    Contact Person<\/strong><\/p>\n

    For informal enquiries about the position, please contact H. F. Escobar Morreale hectorfrancisco.escobar@salud.madrid.org<\/a><\/p>\n

    Please, contact us in order to organize the timeline for the preparation of the proposal. The following documents will be required:<\/p>\n